Cooper Companies Inc (COO) Shares Bought by US Bancorp DE
US Bancorp DE lifted its stake in Cooper Companies Inc (NYSE:COO) by 1.7% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,519 shares of the medical device company’s stock after purchasing an additional 473 shares during the quarter. US Bancorp DE’s holdings in Cooper Companies were worth $5,996,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently bought and sold shares of the company. Janus Henderson Group PLC lifted its position in shares of Cooper Companies by 0.4% in the third quarter. Janus Henderson Group PLC now owns 2,185,268 shares of the medical device company’s stock worth $518,147,000 after purchasing an additional 9,477 shares in the last quarter. Amundi Pioneer Asset Management Inc. lifted its position in shares of Cooper Companies by 2.2% in the third quarter. Amundi Pioneer Asset Management Inc. now owns 1,252,938 shares of the medical device company’s stock worth $297,084,000 after purchasing an additional 26,688 shares in the last quarter. Westfield Capital Management Co. LP lifted its position in shares of Cooper Companies by 47.8% in the third quarter. Westfield Capital Management Co. LP now owns 636,882 shares of the medical device company’s stock worth $151,011,000 after purchasing an additional 206,003 shares in the last quarter. Bank of New York Mellon Corp lifted its position in shares of Cooper Companies by 2.4% in the third quarter. Bank of New York Mellon Corp now owns 449,550 shares of the medical device company’s stock worth $106,592,000 after purchasing an additional 10,717 shares in the last quarter. Finally, Lord Abbett & CO. LLC lifted its position in shares of Cooper Companies by 2.1% in the second quarter. Lord Abbett & CO. LLC now owns 405,831 shares of the medical device company’s stock worth $97,164,000 after purchasing an additional 8,316 shares in the last quarter. 96.35% of the stock is owned by institutional investors and hedge funds.
In other Cooper Companies news, Director Allan E. Rubenstein sold 500 shares of the stock in a transaction that occurred on Wednesday, December 27th. The stock was sold at an average price of $222.00, for a total transaction of $111,000.00. Following the transaction, the director now owns 6,590 shares in the company, valued at $1,462,980. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Gary S. Petersmeyer sold 785 shares of the stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $229.06, for a total value of $179,812.10. The disclosure for this sale can be found here. In the last quarter, insiders have sold 54,385 shares of company stock worth $12,289,463. Corporate insiders own 1.60% of the company’s stock.
Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 EPS for the quarter, topping analysts’ consensus estimates of $2.64 by $0.01. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The firm had revenue of $561.50 million for the quarter, compared to the consensus estimate of $558.86 million. During the same quarter in the prior year, the company posted $2.28 earnings per share. The firm’s revenue was up 8.3% on a year-over-year basis. analysts expect that Cooper Companies Inc will post 11.54 EPS for the current fiscal year.
The business also recently declared a semiannual dividend, which was paid on Friday, February 9th. Shareholders of record on Tuesday, January 23rd were issued a dividend of $0.03 per share. The ex-dividend date of this dividend was Monday, January 22nd. This represents a yield of 0.03%. Cooper Companies’s dividend payout ratio (DPR) is presently 0.80%.
A number of research firms have recently issued reports on COO. KeyCorp reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, October 20th. BMO Capital Markets reissued a “buy” rating and issued a $272.00 price target on shares of Cooper Companies in a research report on Friday, October 13th. Zacks Investment Research downgraded Cooper Companies from a “buy” rating to a “hold” rating in a report on Monday, January 8th. Raymond James Financial restated a “buy” rating and issued a $265.00 price objective on shares of Cooper Companies in a report on Monday, December 4th. Finally, Oppenheimer set a $250.00 price objective on Cooper Companies and gave the stock a “hold” rating in a report on Friday, December 8th. Eight investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $259.70.
TRADEMARK VIOLATION WARNING: “Cooper Companies Inc (COO) Shares Bought by US Bancorp DE” was published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://www.watchlistnews.com/cooper-companies-inc-coo-shares-bought-by-us-bancorp-de/1857111.html.
Cooper Companies Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.